Simple pricing, serious content
Free for discovery. Pro for the deep analysis you'd otherwise pay a consultant $5,000 for.
Free
Discover companies, drugs, targets, and trials
- Search drugs, companies, targets, and indications
- Drug detail pages with summary and indications
- Company profiles with top drugs and therapeutic areas
- Free dashboards — PDUFA Calendar, Trials Explorer, Taxonomy Browser
- Patent landscape pages — Orange Book + global patent family map for 1,300+ drugs
- Research briefs — long-form pharma stories (no paywall)
- Medicare Part D patent cliff analysis (revealing analysis, free to share)
- First PDUFA date per company
- 5-item watchlist
- Full approval timelines and trial lookups
Free forever. No credit card.
Pro
Deep intelligence for people making decisions
- Everything in Free, plus:
- Patent landscape editorial deep-dives — composition anchors, lifecycle layers, biosimilar entry analysis
- Patent Cliff dashboard with revenue arcs (Humira −73%, Revlimid −81%, Stelara −43%)
- Drug-by-drug quarterly revenue from SEC filings (122 drugs)
- Pro dashboards — Patent Cliff, Pipeline Health, Company Portfolios, Competitive Landscape, Trends, Compare, Clinical-Stage, Emerging Biotechs, Activity Signals, Biosimilars, Whitespace, Density
- 95+ molecular target profile pages
- Deep-dive insight reports — Crohn's, UC, Alzheimer's, more coming
- Full clinical trial lists (not just first 5)
- Head-to-head company + drug comparisons (Pipeline Faceoff with PDF export)
- All upcoming PDUFA dates (not just first)
- Unlimited watchlist
- Email alerts (PDUFA dates, drug approvals)
- CSV export
No credit card required. Cancel anytime.
Who pays for Pro?
Three kinds of people find Pro worth more than $99/month.
Feature comparison
| Feature | Free | Pro |
|---|---|---|
| Drug + company detail pages | ✓ | ✓ |
| PDUFA calendar, Trials Explorer, biotech dashboards | ✓ | ✓ |
| First PDUFA date per company | ✓ | ✓ |
| Clinical trial lookups | First 5 | Full list |
| Watchlist | 5 items | Unlimited |
| Patent landscape pages Orange Book + global patent family map for 1,300+ drugs | Basic | + editorial deep-dive |
| Patent cliff with revenue arcs Humira −73%, Revlimid −81%, Stelara −43% — actual SEC data | — | ✓ |
| Drug-by-drug quarterly revenue 122 drugs across 18 companies from SEC filings | — | ✓ |
| Pro dashboards Pipeline Health, Whitespace, Density, Landscape, Trends, Compare, Portfolios, Acquisition Watch, Patent Cliff | — | 9 dashboards |
| Target competitive landscapes Pre-computed deep analysis per molecular target | — | 95+ targets |
| Deep-dive insight reports Crohn's, Ulcerative Colitis, Alzheimer's | — | 3 reports |
| Head-to-head company comparison | — | ✓ |
| Full pipeline by phase (per company) | Counts only | Full list |
| All upcoming PDUFA dates | First only | All |
| CSV export | — | ✓ |
| Email alerts | 5 alerts | Unlimited |
What Pro replaces
Common questions
What data sources does TheraRadar use?
FDA Drugs@FDA for approvals, Orange Book and Purple Book for patents and exclusivity, ClinicalTrials.gov for trials (146,000+ indexed), SEC EDGAR for 8-K/10-K filings and PDUFA dates, and company quarterly reports for drug-level revenue data.
How often is the data updated?
FDA approvals, trials, PDUFA dates, and SEC filings refresh weekly. Patent data refreshes monthly from Orange Book and Purple Book. Drug revenue data refreshes quarterly after each earnings season.
Why is Pro so much cheaper than enterprise tools?
Enterprise intelligence platforms bundle pharma data with custom integrations, support contracts, and enterprise sales overhead that drives their price. TheraRadar skips that — self-serve, no sales calls, no procurement, no onboarding engineers. You get the data you need without the wrapper.
Can I cancel anytime?
Yes. Cancel anytime from your account settings. You'll keep Pro access until the end of your billing period.
What's the difference between monthly and yearly?
Monthly is $99/month billed each month. Yearly is $990 billed once per year — same access, saves $198 (equivalent to 2 months). Cancel anytime from either plan.
Do you offer team plans?
Team plans are coming. Contact us at hello@theraradar.com if you need shared access for a team of 3+.
Is this really "limited-time" pricing?
$99/month and $990/year are launch pricing. Lock in the current rate now and your price stays fixed while you're subscribed.
Ready to go deep?
Start with a 30-day free trial. No credit card required. Cancel anytime during the trial.